Researchers focus flu immunity efforts on nasal ‘border patrol’

Vaccination Vaccination

Researchers at the Peter Doherty Institute for Infection and Immunity have discovered that it is possible to stop flu at the nose, where the virus first encounters the human body, by harnessing the flu-fighting powers of immune cells resident in the nose.

Their findings, published over the weekend in Science Immunology, represent a potential new target for vaccine development.

Associate Professor Aaron Hurt, Senior Research Scientist and Head, Antiviral Susceptibility Analysis, at the World Health Organisation Influenza research centre at the Peter Doherty Institute caught up with the program to discuss this development.

Leave a comment

Your email address will not be published.


*